CoChat
Sign Up
Cited by 189

Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell–Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury

Bell, Catherine C., Lauschke, Volker M., Vorrink, Sabine U., Palmgren, Henrik, Duffin, Rodger, Andersson, Tommy B., Ingelman-Sundberg, Magnus·2017·Drug Metabolism and Disposition
DOI 10.1124/dmd.116.074369PMC PMC5363699
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1124/dmd.116.074369

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 80

  1. Anderson N Borlak J (2006) Drug-induced phospholipidosis. FEBS Lett 580: 5533– 5540. 16979167
  2. Anthérieu S Rogue A Fromenty B Guillouzo A Robin MA (2011) Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG cells. Hepatology 53: 1895– 1905. 21391224
  3. Ayd FJ Jr (1956) The dermatologic and systemic manifestations of chlorpromazine hypersensitivity; their clinical significance and management. J Nerv Ment Dis 124: 84– 87. 13416925
  4. Bates DW Spell N Cullen DJ Burdick E Laird N Petersen LA Small SD Sweitzer BJ Leape LL Adverse Drug Events Prevention Study Group (1997) The costs of adverse drug events in hospitalized patients. JAMA 277: 307– 311. 9002493
  5. Bell CC Hendriks DFG Moro SML Ellis E Walsh J Renblom A Fredriksson Puigvert L Dankers ACA Jacobs F Snoeys J (2016) Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci Rep 6: 25187. 27143246 PMC4855186
  6. Bradley JD Brandt KD Katz BP Kalasinski LA Ryan SI (1991) Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 325: 87– 91. 2052056
  7. Chapman KL Holzgrefe H Black LE Brown M Chellman G Copeman C Couch J Creton S Gehen S Hoberman A (2013) Pharmaceutical toxicology: designing studies to reduce animal use, while maximizing human translation. Regul Toxicol Pharmacol 66: 88– 103. 23524271
  8. Chen HL Liu YJ Chen HL Wu SH Ni YH Ho MC Lai HS Hsu WM Hsu HY Tseng HC (2008) Expression of hepatocyte transporters and nuclear receptors in children with early and late-stage biliary atresia. Pediatr Res 63: 667– 673. 18327154
  9. Classen DC Pestotnik SL Evans RS Lloyd JF Burke JP (1997) Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 277: 301– 306. 9002492
  10. Ellinger-Ziegelbauer H Stuart B Wahle B Bomann W Ahr HJ (2004) Characteristic expression profiles induced by genotoxic carcinogens in rat liver. Toxicol Sci 77: 19– 34. 14600272
  11. Fey SJ Wrzesinski K (2012) Determination of drug toxicity using 3D spheroids constructed from an immortal human hepatocyte cell line. Toxicol Sci 127: 403– 411. 22454432 PMC3355318
  12. Fromenty B Fisch C Berson A Letteron P Larrey D Pessayre D (1990) Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II. J Pharmacol Exp Ther 255: 1377– 1384. 1979817
  13. Fulgencio JP Kohl C Girard J Pégorier JP (1996) Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats. Diabetes 45: 1556– 1562. 8866561
  14. Funk C Pantze M Jehle L Ponelle C Scheuermann G Lazendic M Gasser R (2001) Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate. Toxicology 167: 83– 98. 11557132
  15. García Rodríguez LA Ruigómez A Jick H (1997) A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom. Pharmacotherapy 17: 721– 728. 9250549
  16. Geba GP Weaver AL Polis AB Dixon ME Schnitzer TJ Vioxx, Acetaminophen, Celecoxib Trial (VACT) Group (2002) Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial. JAMA 287: 64– 71. 11754710
  17. Gerets HHJ Tilmant K Gerin B Chanteux H Depelchin BO Dhalluin S Atienzar FA (2012) Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol 28: 69– 87. 22258563 PMC3303072
  18. Gunness P Mueller D Shevchenko V Heinzle E Ingelman-Sundberg M Noor F (2013) 3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies. Toxicol Sci 133: 67– 78. 23377618
  19. Hakkola J Raunio H Purkunen R Saarikoski S Vähäkangas K Pelkonen O Edwards RJ Boobis AR Pasanen M (2001) Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers. Biol Neonate 80: 193– 201. 11585982
  20. Hamamoto R Furukawa Y Morita M Iimura Y Silva FP Li M Yagyu R Nakamura Y (2004) SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat Cell Biol 6: 731– 740. 15235609
  21. Hassan AM Sheashaa HA Abdel Fatah MF Ibrahim AZ Gaber OA (2006) Does aflatoxin as an environmental mycotoxin adversely affect the renal and hepatic functions of Egyptian lactating mothers and their infants? A preliminary report. Int Urol Nephrol 38: 339– 342. 16868707
  22. Horikawa M Kato Y Tyson CA Sugiyama Y (2003) Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans. Drug Metab Pharmacokinet 18: 16– 22. 15618715
  23. Johnson WW Guengerich FP (1997) Reaction of aflatoxin B1 exo-8,9-epoxide with DNA: kinetic analysis of covalent binding and DNA-induced hydrolysis. Proc Natl Acad Sci USA 94: 6121– 6125. 9177180 PMC21012
  24. Jossé R Dumont J Fautrel A Robin MA Guillouzo A (2012) Identification of early target genes of aflatoxin B1 in human hepatocytes, inter-individual variability and comparison with other genotoxic compounds. Toxicol Appl Pharmacol 258: 176– 187. 22100608
  25. Kenne K Skanberg I Glinghammar B Berson A Pessayre D Flinois JP Beaune P Edebert I Pohl CD Carlsson S (2008) Prediction of drug-induced liver injury in humans by using in vitro methods: the case of ximelagatran. Toxicol In Vitro 22: 730– 746. 18191936
  26. Kennedy JA Unger SA Horowitz JD (1996) Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone. Biochem Pharmacol 52: 273– 280. 8694852
  27. Kia R Sison RLC Heslop J Kitteringham NR Hanley N Mills JS Park BK Goldring CEP (2013) Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet? Br J Clin Pharmacol 75: 885– 896. 22703588 PMC3612706
  28. Klein S Mueller D Schevchenko V Noor F (2014) Long-term maintenance of HepaRG cells in serum-free conditions and application in a repeated dose study. J Appl Toxicol 34: 1078– 1086. 24114766
  29. Krenkel O Mossanen JC Tacke F (2014) Immune mechanisms in acetaminophen-induced acute liver failure. Hepatobiliary Surg Nutr 3: 331– 343. 25568858 PMC4273118
  30. Lauschke VM Hendriks DFG Bell CC Andersson TB Ingelman-Sundberg M (2016 a) Novel 3D culture systems for studies of human liver function and assessments of the hepatotoxicity of drugs and drug candidates. Chem Res Toxicol 29:1936–1955. 27661221
  31. Lauschke VM Ingelman-Sundberg M (2016) The importance of patient-specific factors for hepatic drug response and toxicity. Int J Mol Sci 17: 1714– 1727. PMC5085745 27754327
  32. Lauschke VM Mkrtchian S Ingelman-Sundberg M (2016 b) The role of microRNAs in liver injury at the crossroad between hepatic cell death and regeneration. Biochem Biophys Res Commun DOI: 10.1016/j.bbrc.2016.10.084 [published ahead of print]. 27789285 · DOI · Paper page
  33. Lauschke VM Vorrink SU Moro SM Rezayee F Nordling Å Hendriks DF Bell CC Sison-Young R Park BK Goldring CE (2016 c) Massive rearrangements of cellular microRNA signatures are key drivers of hepatocyte dedifferentiation. Hepatology 64: 1743– 1756. 27532775
  34. Lehmann JM Moore LB Smith-Oliver TA Wilkison WO Willson TM Kliewer SA (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270: 12953– 12956. 7768881
  35. Li Y Wan DF Su JJ Cao J Ou C Qiu XK Ban KC Yang C Qin LL Luo D (2004) Differential expression of genes during aflatoxin B(1)-induced hepatocarcinogenesis in tree shrews. World J Gastroenterol 10: 497– 504. 14966905 PMC4716968
  36. Lim PLK Liu J Go ML Boelsterli UA (2008) The mitochondrial superoxide/thioredoxin-2/Ask1 signaling pathway is critically involved in troglitazone-induced cell injury to human hepatocytes. Toxicol Sci 101: 341– 349. 17975114
  37. Loi CM Alvey CW Vassos AB Randinitis EJ Sedman AJ Koup JR (1999) Steady-state pharmacokinetics and dose proportionality of troglitazone and its metabolites. J Clin Pharmacol 39: 920– 926. 10471982
  38. Macé K Aguilar F Wang JS Vautravers P Gómez-Lechón M Gonzalez FJ Groopman J Harris CC Pfeifer AM (1997) Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines. Carcinogenesis 18: 1291– 1297. 9230270
  39. Masubuchi Y (2006) Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: a review. Drug Metab Pharmacokinet 21: 347– 356. 17072088
  40. McCarthy TC Pollak PT Hanniman EA Sinal CJ (2004) Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation. J Pharmacol Exp Ther 311: 864– 873. 15265979
  41. Mueller D, Krämer L, Hoffmann E, Klein S, and Noor F (2014) 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies. Toxicol In Vitro 28:104–112. 23850736
  42. Nadanaciva S Bernal A Aggeler R Capaldi R Will Y (2007) Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays. Toxicol In Vitro 21: 902– 911. 17346924
  43. Natarajan K Xie Y Baer MR Ross DD (2012) Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. Biochem Pharmacol 83: 1084– 1103. 22248732 PMC3307098
  44. Neve EPA Köfeler H Hendriks DFG Nordling Å Gogvadze V Mkrtchian S Näslund E Ingelman-Sundberg M (2015) Expression and function of mARC: roles in lipogenesis and metabolic activation of ximelagatran. PLoS One 10: e0138487. 26378779 PMC4574727
  45. Nies AT Koepsell H Winter S Burk O Klein K Kerb R Zanger UM Keppler D Schwab M Schaeffeler E (2009) Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver. Hepatology 50: 1227– 1240. 19591196
  46. Ostapowicz G Fontana RJ Schiødt FV Larson A Davern TJ Han SHB McCashland TM Shakil AO Hay JE Hynan L U.S. Acute Liver Failure Study Group (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137: 947– 954. 12484709
  47. Park BK Boobis A Clarke S Goldring CEP Jones D Kenna JG Lambert C Laverty HG Naisbitt DJ Nelson S (2011) Managing the challenge of chemically reactive metabolites in drug development. Nat Rev Drug Discov 10: 292– 306. 21455238
  48. Parmentier C Truisi GL Moenks K Stanzel S Lukas A Kopp-Schneider A Alexandre E Hewitt PG Mueller SO Richert L (2013) Transcriptomic hepatotoxicity signature of chlorpromazine after short- and long-term exposure in primary human sandwich cultures. Drug Metab Dispos 41: 1835– 1842. 23913027
  49. Pradip A Steel D Jacobsson S Holmgren G Ingelman-Sundberg M Sartipy P Björquist P Johansson I Edsbagge J (2016) High content analysis of human pluripotent stem cell derived hepatocytes reveals drug induced steatosis and phospholipidosis. Stem Cells Int 2016: 2475631. 26880940 PMC4736406
  50. Purcell SM Moran JL Fromer M Ruderfer D Solovieff N Roussos P O’Dushlaine C Chambert K Bergen SE Kähler A (2014) A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506: 185– 190. 24463508 PMC4136494
  51. Raijmakers MT Steegers EA Peters WH (2001) Glutathione S-transferases and thiol concentrations in embryonic and early fetal tissues. Hum Reprod 16: 2445– 2450. 11679536
  52. Ramaiahgari SC den Braver MW Herpers B Terpstra V Commandeur JNM van de Water B Price LS (2014) A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies. Arch Toxicol 88: 1083– 1095. 24599296
  53. Regenthal R Krueger M Koeppel C Preiss R (1999) Drug levels: therapeutic and toxic serum/plasma concentrations of common drugs. J Clin Monit Comput 15: 529– 544. 12578052
  54. Ros E Small DM Carey MC (1979) Effects of chlorpromazine hydrochloride on bile salt synthesis, bile formation and biliary lipid secretion in the rhesus monkey: a model for chlorpromazine-induced cholestasis. Eur J Clin Invest 9: 29– 41. 110598
  55. Russo MW Galanko JA Shrestha R Fried MW Watkins P (2004) Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 10: 1018– 1023. 15390328
  56. Sakai Y Yamagami S Nakazawa K (2010) Comparative analysis of gene expression in rat liver tissue and monolayer- and spheroid-cultured hepatocytes. Cells Tissues Organs 191: 281– 288. 20051666
  57. Schutte M Fox B Baradez M-O Devonshire A Minguez J Bokhari M Przyborski S Marshall D (2011) Rat primary hepatocytes show enhanced performance and sensitivity to acetaminophen during three-dimensional culture on a polystyrene scaffold designed for routine use. Assay Drug Dev Technol 9: 475– 486. 21675871
  58. Schützer KM Wall U Lönnerstedt C Ohlsson L Teng R Sarich TC Eriksson UG (2004) Bioequivalence of ximelagatran, an oral direct thrombin inhibitor, as whole or crushed tablets or dissolved formulation. Curr Med Res Opin 20: 325– 331. 15025841
  59. Selim K Kaplowitz N (1999) Hepatotoxicity of psychotropic drugs. Hepatology 29: 1347– 1351. 10216114
  60. Sevilla-Tirado FJ González-Vallejo EB Leary AC Breedt HJ Hyde VJ Fernández-Hernando N (2003) Bioavailability of two new formulations of paracetamol, compared with three marketed formulations, in healthy volunteers. Methods Find Exp Clin Pharmacol 25: 531– 535. 14571283
  61. Sgro C Clinard F Ouazir K Chanay H Allard C Guilleminet C Lenoir C Lemoine A Hillon P (2002) Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 36: 451– 455. 12143055
  62. Sison-Young RL Lauschke VM Johann E Alexandre E Anthérieu S Aerts H Gerets HHJ Labbe G Hoët D Dorau M (2016) A multicenter assessment of single-cell models aligned to standard measures of cell health for prediction of acute hepatotoxicity. Arch Toxicol DOI: 10.1007/s00204-016-1745-4 [published online ahead of print]. PMC5316403 27344343 · DOI
  63. Soyama A Hanioka N Saito Y Murayama N Ando M Ozawa S Sawada J (2002) Amiodarone N‐deethylation by CYP2C8 and its variants, CYP2C8*3 and CYP2C8 P404A. Pharmacol Toxicol 91: 174– 178. 12530467
  64. Spaniol M Bracher R Ha HR Follath F Krähenbühl S (2001) Toxicity of amiodarone and amiodarone analogues on isolated rat liver mitochondria. J Hepatol 35: 628– 636. 11690709
  65. Takara K Sakaeda T Okumura K (2006) An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy. Curr Pharm Des 12: 273– 286. 16454744
  66. Takayama K Kawabata K Nagamoto Y Kishimoto K Tashiro K Sakurai F Tachibana M Kanda K Hayakawa T Furue MK (2013) 3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing. Biomaterials 34: 1781– 1789. 23228427
  67. Tasnim F Toh YC Qu Y Li H Phan D Narmada BC Ananthanarayanan A Mittal N Meng RQ Yu H (2016) Functionally enhanced human stem cell derived hepatocytes in galactosylated cellulosic sponges for hepatotoxicity testing. Mol Pharm 13: 1947– 1957. 27157693
  68. Tirmenstein MA Hu CX Gales TL Maleeff BE Narayanan PK Kurali E Hart TK Thomas HC Schwartz LW (2002) Effects of troglitazone on HepG2 viability and mitochondrial function. Toxicol Sci 69: 131– 138. 12215667
  69. Tostões RM Leite SB Serra M Jensen J Björquist P Carrondo MJT Brito C Alves PM (2012) Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing. Hepatology 55: 1227– 1236. 22031499
  70. Trivier JM Libersa C Belloc C Lhermitte M (1993) Amiodarone N-deethylation in human liver microsomes: involvement of cytochrome P450 3A enzymes (first report). Life Sci 52: PL91– PL96. 8445979
  71. Vale JA Proudfoot AT (1995) Paracetamol (acetaminophen) poisoning. Lancet 346: 547– 552. 7658783
  72. Wang J Duncan D Shi Z Zhang B (2013) WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res 41: W77– W83. 23703215 PMC3692109
  73. Watkins PB Kaplowitz N Slattery JT Colonese CR Colucci SV Stewart PW Harris SC (2006) Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 296: 87– 93. 16820551
  74. Watson RG Olomu A Clements D Waring RH Mitchell S Elias E (1988) A proposed mechanism for chlorpromazine jaundice--defective hepatic sulphoxidation combined with rapid hydroxylation. J Hepatol 7: 72– 78. 3183354
  75. Weiske J Albring KF Huber O (2007) The tumor suppressor Fhit acts as a repressor of beta-catenin transcriptional activity. Proc Natl Acad Sci USA 104: 20344– 20349. 18077326 PMC2154433
  76. Williams JH Phillips TD Jolly PE Stiles JK Jolly CM Aggarwal D (2004) Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. Am J Clin Nutr 80: 1106– 1122. 15531656
  77. Xu JJ Henstock PV Dunn MC Smith AR Chabot JR de Graaf D (2008) Cellular imaging predictions of clinical drug-induced liver injury. Toxicol Sci 105: 97– 105. 18524759
  78. Yoshii K Kobayashi K Tsumuji M Tani M Shimada N Chiba K (2000) Identification of human cytochrome P450 isoforms involved in the 7-hydroxylation of chlorpromazine by human liver microsomes. Life Sci 67: 175– 184. 10901285
  79. Zollner G Fickert P Zenz R Fuchsbichler A Stumptner C Kenner L Ferenci P Stauber RE Krejs GJ Denk H (2001) Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 33: 633– 646. 11230744
  80. Zollner G Wagner M Fickert P Silbert D Gumhold J Zatloukal K Denk H Trauner M (2007) Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis. Liver Int 27: 920– 929. 17696930

Cited by

Sorted by citations

Authors
Bell, C. C., Lauschke, V. M., Vorrink, S. U., Palmgren, H., Duffin, R., Andersson, T. B., & Ingelman-Sundberg, M.
Venue
Drug Metabolism and Disposition
Publisher
Elsevier BV
Published
2017-04
Volume
45
Issue
4
Pages
419-429
ISSN
0090-9556
DOI
10.1124/dmd.116.074369
PMC
PMC5363699
Cited by
189
References
7
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review